Air-assisted cloud point extraction coupled with inductively coupled plasma optical emission spectroscopy for determination of samarium in environmental samples.

For the first time, air-assisted cloud point extraction (AACPE) was presented to preconcentrate metal ions. The procedure was conjugated with inductively coupled plasma-optical emission spectroscopy for determination of samarium. In this procedure, samarium ions were complexed with aluminon and extracted into Triton X-114 in the presence of potassium iodide. The mixture was repeatedly sucked and dispersed with a syringe (three times) to create cloud solution. Experimental factors that affect the extraction competence of the AACPE procedure, such as pH, amount of aluminon and Triton X-114, salt addition, number of suction/injection cycles, and centrifugation rate and time, have been investigated and optimized. A linear calibration curve from 0.2 to 200.0 µg L-1 with enrichment factor and detection limit of 102 and 0.06 µg L-1, respectively, was established under the optimum experimental conditions. The approach was used to determine samarium in wastewater and rock samples, with recoveries ranging from 98% to 99%.

Management of SARS-CoV-2 Infection: Key Focus in Macrolides Efficacy for COVID-19.

Macrolides (e.g., erythromycin, fidaxomicin, clarithromycin, and azithromycin) are a class of bacteriostatic antibiotics commonly employed in medicine against various gram-positive and atypical bacterial species mostly related to respiratory tract infections, besides they possess anti-inflammatory and immunomodulatory effects. Coronavirus Disease 2019 (COVID-19) is an infectious disease caused by the severe acute respiratory syndrome of coronavirus 2 (SARS-CoV-2). It was first detected in Wuhan, Hubei, China, in December 2019 and resulted in a continuing pandemic. Macrolides have been extensively researched as broad adjunctive therapy for COVID-19 due to its immunostimulant abilities. Among such class of drugs, azithromycin is described as azalide and is well-known for its ability to decrease the production of pro-inflammatory cytokines, including matrix metalloproteinases, tumor necrosis factor-alpha, interleukin (IL)-6, and IL-8. In fact, a report recently published highlighted the effectiveness of combining azithromycin and hydroxychloroquine for COVID-19 treatment. Indeed, it has been underlined that azithromycin quickly prevents SARS-CoV-2 infection by raising the levels of both interferons and interferon-stimulated proteins at the same time which reduces the virus replication and release. In this sense, the current review aims to evaluate the applications of macrolides for the treatment of COVID-19.